96898 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Vesiculins
#3302Amylin analogs and pharmaceutical compositions thereof
#3303Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof
#3304Methods and compositions for heptameric targeting ligands
#3305Glycosylated specificity exchangers
#3306Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
#3307Protein skeletal module which increases the binding affinity and binding specificity of active polypeptides
#3308Methods of preventing or treating brain diseases
#3309Targeting complement factor H for treatment of diseases
#3310Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
#3311Fusion proteins comprising an engineered knottin peptide and uses thereof
#3312Compositions and methods for determining genetic polymorphisms in the TMEM216 gene
#3313gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis
#3314Lafora's disease gene
#3315Antibodies that specifically bind SOST and WISE peptides
#3316Methods and compositions for the treatment of cancer or other diseases
#3317Peptides that are modulators of the protein TRF2 and compositions containing same
#3318Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides
#3319Small molecule-dependent inteins and uses thereof
#3320NEUROBLASTOMA HOST CELL LINE FOR STABLY EXPRESSING HUMAN EXOGENOUS PROTEIN AND METHOD
#3321Antibody to secreted polypeptide
#3322Antibodies to TTR and methods of use
#3323Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
#3324Method for isolating osteopontin using feeds containing CMP or casein species
#3325Muteins of human lipocalin 2 with affinity for CTLA-4
#3326PERIOSTIN-INDUCED PANCREATIC REGENERATION
#3327NUCLEIC ACID AND CORRESPONDING PROTEIN NAMED 158P1D7 USEFUL IN THE TREATMENT AND DETECTION OF BLADDER AND OTHER CANCERS
#3328Chimeric antibacterial polypeptides
#3329Biological active proteins having increased in vivo and/or in vitro stability
#3330Device and method for production and analysis of prions
#3331SHORT-FORM HUMAN MD-2 AS A NEGATIVE REGULATOR OF TOLL-LIKE RECEPTOR 4 SIGNALING
#3332Compositions having antiangiogenic activity and uses thereof
#3333Signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins
#3334Production of FMDV-resistant livestock by allele substitution
#3335Ribonucleic acid binding motif protein 20 sequence variants
#3336FILIP1L nucleic acid fragments
#3337Polynucleotides and Polypeptides Associated with Trophoblast Cell Death, Differentiation, Invasion and/or Cell Fusion and Turnover
#3338Compositions and methods for promoting wound healing and tissue regeneration
#3339Expression vector for animal cells
#3340Antibody reacting with native Cochlin-tomoprotein (CTP) and method for measuring CTP using same
#3341Methods of screening compounds for the fibril formation of Aβ peptides based on a decreased trimer/monomer ratio of a chaperone protein
#3342Cyclic CRF antagonist peptides
#3343PCA3 genes
#3344Method of diagnosing cancer and diagnosis kit using measurement of NK cell activity
#3345Botulinum neurotoxin a receptor and the use thereof
#3346Viral vectors for the treatment of retinal dystrophy
#3347Bioactive Peptides and Proteins Containing Bioactive Peptides, their Uses and Processes for Making the Same
#3348Methods for treating metabolic syndrome with Cthrc1 polypeptide
#3349LONG-ACTING IL-1 RECEPTOR ANTAGONISTS
#3350LIPOSOMES FOR PROTECTION AGAINST TOXIC COMPOUNDS
#3351USE OF HEPATOCYTE NUCLEAR FACTOR 1A IN PREPARATION OF DRUG FOR TREATING MALIGNANT SOLID TUMOR DISEASE
#3352Imaging methods using engineered integrin binding peptides
#3353Natriuretic polypeptides
#3354SCAFFOLD PEPTIDES
#3355Designed ankyrin repeat proteins binding to platelet-derived growth factor
#3356Activity enhancer for anticancer agent
#3357Beta-catenin targeting peptides and uses thereof
#3358Apolipoprotein AIV as an antidiabetic peptide
#3359Bioactive peptides and methods of using same
#3360PHOSPHORYLATED DERIVATIVES OF A U1-70K PEPTIDE AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE PATHOLOGIES
#3361Novel Polypeptides Involved in Immune Response
#3362EDN3-LIKE PEPTIDES AND USES THEREOF
#3363ATIP3 AND BIOLOGICALLY ACTIVE FRAGMENTS THEREOF FOR USE IN THE TREATMENT OF CANCER
#3364Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions for methods of treating tissue injury
#3365Homeobox gene
#3366COMPOSITIONS AND METHODS FOR TREATING AN ACTIVATED B-CELL DIFFUSE LARGE B-CELL LYMPHOMA
#3367Class of therapeutic protein based molecules
#3368Methods and compositions for producing active vitamin K-dependent proteins
#3369Chimeric fibronectin matrix mimetics and uses therof
#3370MARKER COMPOSITION COMPRISING S1P PROTEIN FOR PREDICTION OF RISK IN OSTEOPOROTIC FRACTURE AND OSTEOPOROSIS
#3371Methods and compositions for treating inflammation
#3372MAMMALIAN CELL SURFACE ANTIGENS; RELATED REAGENTS
#3373Pharmacodiagnosis Test Targeting Oncology and Neurodegeneration
#3374Peptides that modulate complex SASPase-FLG2
#3375Variants of human GDNF
#3376Peptides for the specific binding of RNA targets
#3377Spinal muscular atrophy diagnostic methods
#3378Methods and compositions related to Staufen 1 binding sites formed by duplexing Alu elements
#3379Muteins of hNGAL and related proteins with affinity for a given target
#3380Use of endostatin peptides for the treatment of fibrosis
#3381NUCLEIC ACIDS ENCODING PEPTIDES FOR TREATING WOUNDS, ANTI-ANGIOGENIC COMPOUNDS AND USES THEREOF
#3382Non-natural consensus albumin binding domains
#3383EXTENDED RECOMBINANT POLYPEPTIDE-MODIFIED C-PEPTIDE
#3384Methods and compositions for screening and treating developmental disorders
#3385Method of inducing an immune response by administering WDRPUH epitope peptides
#3386Method for expansion of stem cells and the use of such cells
#3387Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis
#3388COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROSIS
#3389WDHD1 peptides and vaccines including the same
#3390Antagonists of GRASP55 for use as a medicament
#3391USP2A PEPTIDES AND ANTIBODIES
#3392Methods of making antibodies that bind polypeptides involved in the process of bone remodeling
#3393Pre-Ligand assembly domain of the IL-17 receptor
#3394Transducible polypeptides for modifying metabolism
#3395Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3)
#3396Microcrystalline Y receptor agonists
#3397Capping modules for designed ankyrin repeat proteins
#3398Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use
#3399Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases
#3400COMPOSITIONS AND METHODS FOR THE DELIVERY OF NITRIC OXIDE
#3401TARGETING SENESCENT AND CANCER CELLS FOR SELECTIVE KILLING BY INTERFERENCE WITH FOXO4
#3402COMPOSITIONS AND METHODS FOR THE DELIVERY OF OXYGEN
#3403ENGINEERED KINETOCHORES AND USES THEREOF
#3404SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same
#3405Use of the cathelicidin LL-37 and derivatives thereof for wound healing
#3406Compositions Targeting the Soluble Extracellular Domain of E-Cadherin and Related Methods for Cancer Therapy
#3407Well-defined oligomers of ubiquitin and ubiquitin-like polypeptides, and methods for preparing same
#3408DPP-IV RESISTANT GIP HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES
#3409Peptide-lipid constructs and their use in diagnostic and therapeutic applications
#3410Reporter genes for magnetic resonance imaging and methods of use thereof
#3411Compositions and methods for promoting wound healing and tissue regeneration
#3412DIAGNOSTIC MARKER FOR MELANOMA, PHARMACEUTICAL COMPOSITION COMPRISING INHIBITOR OF THE FUNCTION OF THE HISTATIN-1 PROTEIN AND IMMUNOSUPPRESSOR
#3413Methods and vectors for cell immortalisation
#3414Substituted 1,3-thiazoles as heat shock transcription factor 1 activators
#3415Partial Region Polypeptide of REIC/Dkk-3 Protein
#3416Methods for isolation, use and analysis of ferritin
#3417Method of enhancing efficacy of blood transfusions
#3418Glial cell line-derived neurotrophic factor (GDNF) compositions and use thereof
#3419Modified polynucleotides for the production of biologics and proteins associated with human disease
#3420Modified polynucleotides for the production of secreted proteins
#3421Radiofluorinated compounds and their preparation
#3422SERUM AMYLOID P PROTEIN
#3423MO-1, A Gene Associated With Morbid Obesity
#3424PLIF multimeric peptides and uses thereof
#3425Fibronectin binding domains with reduced immunogenicity
#3426Polynucleotide for use in treatment of influenza A virus induced diseases, encoding modified Mx protein, said modified Mx protein, and a transgenic animal expressing gene encoding modified Mx protein
#3427Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding such
#3428Compositions for treatment of neurodegenerative diseases
#3429Designed repeat proteins binding to serum albumin
#3430Method of inducing labor or treating pre-eclampsia by administering relaxin analogs
#3431Antimicrobial peptides and derived metapeptides
#3432Compositions comprising signal peptide-containing proteins
#3433Use of GDF traps to treat anemia
#3434Mammalian cell expressing light-activated ion channel protein (VChR1)
#3435Human ULIP/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
#3436Biosynthetic Polypeptide Fusion Inhibitors
#3437Nucleic acid fragments from a ribosomal protein promoter for enhancing gene expression
#3438Serological markers for detecting colorectal cancer and their application for inhibiting colorectal cancer cells
#3439Substances and compositions for enhancing DNA repair and methods of use
#3440Novel Peptide Involved in Energy Homeostasis
#3441Fusion protein comprising small heat shock protein, cage protein formed thereby, and novel use thereof
#3442Myomegalin variant 8
#3443Method for inducing immunity with a peptide fragment from human CAPRIN-1
#3444Delivery of MECP2 polynucleotide using recombinant AAV9
#3445TEX14 PEPTIDES AS NOVEL ANTITUMOR AGENTS
#3446Specific active site inhibitors of enzymes and methods of producing same
#3447Recombinant production of vascular endothelial growth factor
#3448Mutant NGAL proteins and uses thereof
#3449Chimeric inhibitor molecules of complement activation
#3450Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
#3451Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof
#3452Methods of Generation and Treatment with Modified Derivatives of HSP 70
#3453SITE-SPECIFIC CHEMICAL MODIFICATION OF PROTEINS AT THEIR N-TERMINI, ENABLING THE FORMATION OF HOMOGENEOUS ADDUCTS
#3454Immunoregulatory peptides and methods of use
#3455Cerberus/Coco derivatives and uses thereof
#3456Immunoregulatory peptides and methods of use
#3457Immunoregulatory peptides and methods of use
#3458Preparation of recombinant human plasma phospholipid transfer protein (PLTP) from the milk of transgenic rabbits
#3459Human Secreted Proteins
#3460MAMMALIAN GENES; RELATED REAGENTS
#3461Methods for modulating D1-D2 dopamine receptor coupling and function
#3462INTRACELLULAR IMMUNITY
#3463RNA containing modified nucleosides and methods of use thereof
#3464Methods and compositions inhibiting tumor cell proliferation
#3465Frataxin mutants
#3466Polynucleotides encoding recombinant lubricin molecules and uses thereof
#3467SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE (SPARC) AS CHEMOTHERAPEUTIC SENSITIZERS
#3468Controlled release of ocular biopharmaceuticals using bioresponsive protein polymers
#3469Compositions and methods useful in enhancement of memory
#3470Fibronectin binding domains with reduced immunogenicity
#3471Recombinant allergen
#3472METHODS AND COMPOSITIONS FOR IMPROVING SLEEP AND MEMORY
#3473Chlorotoxin variants, conjugates, and methods for their use
#3474TUMOR GROWTH CONTROLLING METHOD TARGETING GALACTOSYLCERAMIDE EXPRESSION FACTOR-1
#3475ANTIBODIES WITH T-CELL RECEPTOR LIKE SPECIFICITY TOWARDS NATIVE COMPLEXES OF MHC CLASS II AND DIABETES-ASSOCIATED AUTOANTIGENIC PEPTIDES
#3476Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis
#3477MIA-2 PROTEIN
#3478PROTEIN PRODUCTION
#3479Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof
#3480Compound and method for treatment of alzheimer's disease and familial dementia
#3481Modified ghrelin peptides
#3482Use of -long leader sequence for transmembrane delivery of molecules
#3483NOGO Receptor-Mediated Blockade of Axonal Growth
#3484TARGETING COMPOUNDS
#3485β2-glycoprotein I peptide inhibitors
#3486Method for treating wrinkles using a paralytic peptide from the shrew
#3487Neurogenin
#3488Anticancer fusion protein comprising trail
#3489Cell-penetrating peptides and uses thereof
#3490EML4-ALK fusion gene
#3491Method for identifying hetero-multimeric modified ubiquitin proteins with binding capability to ligands
#3492RHAMM binding peptides
#3493Methods of determination of activation or inactivation of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) hormonal systems
#3494Colorimetric and fluorescent proteins
#3495ISOLATION OF MESENCHYMAL STEM CELLS
#3496FUSION PROTEINS OF NATURAL HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN Fc COMPOSITIONS
#3497Therapy for subarachnoid hemorrhage and ischemia
#3498ISOLATED PROTEIN MEDICAMENT
#3499HSP70 fusion protein conjugates and uses thereof
#3500Antibody producing non-human mammals
#3501RNF8-FHA domain-modified protein and method of producing the same
#3502Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
#3503Akt activity specifically inhibiting polypeptide
#3504Diagnosis of hereditary spastic paraplegias (HSP) by identification of a mutation in the ZFYVE26 gene or protein
#3505Method for inhibiting HIV replication in mammal and human cells
#3506Engineering surface epitopes to improve protein crystallization
#3507MAMMALIAN CELL SURFACE ANTIGENS; RELATED REAGENTS
#3508Protein complex for intracellular delivery and uses thereof
#3509PEPTIDES FOR THE REGULATION OF NEUROTRANSMITTER SEQUESTRATION AND RELEASE
#3510Tango 240 nucleic acids and uses thereof
#3511Method for Enriching Methylated CpG Sequences
#3512Use of peptides as transporters intended for the internalization of molecules of interest into target cells
#3513NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF
#3514COLON DISEASE TARGETS AND USES THEREOF
#3515USP2a peptides and antibodies
#3516Peptides useful as cell-penetrating peptides
#3517Telomerase activity inhibiting peptide and manufacturing method and application thereof
#3518Disease-associated proteins
#3519NEUBLASTIN VARIANTS
#3520Genes from 20q13 amplicon and their uses
#3521Hyaluronic acid decomposition-promoting factor and inhibitor thereof
#3522BIOMARKER SPECIFIC TO BRAIN/NERVE OR SPECIFIC TO NEURONAL DIFFERENTIATION
#3523Bone morphogenic protein binding peptide
#3524Tear lipocalin in muteins binding IL-4 R alpha
#3525SEROLOGICAL MARKERS FOR DETECTING COLORECTAL CANCER AND THEIR APPLICATION FOR INHIBITING COLORECTAL CANCER CELLS
#3526Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same
#3527Muteins of human lipocalin 2 (LcnC,hNGAL) with affinity for a given target
#3528Multiple signaling pathways induced by hexvalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
#3529CANCER-SPECIFIC GENETIC REARRANGEMENTS
#3530Compositions and methods for brown fat induction and activity using FNDC5
#3531Use of RGM and its modulators
#3532Secreted protein acidic and rich in cysteine (SPARC) protein SRM assay
#3533Small heat shock proteins and active fragments thereof as a therapy for inflammation and ischemia
#3534COLON CANCER TARGETS AND USES THEREOF
#3535Sperm-specific cation channel, CatSper4, and uses therefor
#3536Gene for Identifying Individuals with Familial Dysautonomia
#3537UCP4
#3538CHLAMYDOMONAS INTRAFLAGELLAR TRANSPORT 88 (IFT-88)
#3539Target of EGR1 (TOE1) polypeptides for inhibition of HIV
#3540Polypeptide acting to enhance ischemic diseases
#3541INDUCIBLE EXPRESSION OF SGLT5, METHODS AND KITS USING THE SAME
#3542Method for producing cAMP using chimeric olfactory receptor
#3543Use of immunesuppressant receptor
#3544Chemical preparation of polyubiquitin chains
#3545Traceability of cellular cycle anomalies targeting oncology and neurodegeneration
#3546Gene targets associated with amyotrophic lateral sclerosis and methods of use thereof
#3547Compositions and methods for the treatment of immune related diseases
#3548Translocation and mutant ROS kinase in human non-small cell lung carcinoma
#3549TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA
#3550HYPOXIA-RELATED GENE SIGNATURES FOR CANCER CLASSIFICATION
#3551Polypeptide expressed in the stratum corneum and thereof
#3552Inhibitors of mitochondrial fission and methods of use thereof
#3553Biocatalysts for ezetimibe synthesis
#3554Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
#3555TREATMENT OF TYPE 2 DIABETES, METABOLIC SYNDROME, MYOCARDIAL INJURY AND NEURODEGENERATION WITH HUMANIN AND ANALOGS THEREOF
#3556METHODS AND COMPOSITIONS RELATING TO MULTICILIATE CELL DIFFERENTIATION
#3557Allergen
#3558Biological Materials and Uses Thereof
#3559Chemical preparation of ubiquitin thioesters and modifications thereof
#3560Glycosylated specificity exchangers
#3561Induction of tumor immunity by variants of folate binding protein
#3562NOVEL HUMAN GENES RELATING TO RESPIRATORY DISEASES AND OBESITY
#3563GENES INVOLVED IN INFLAMMATORY BOWEL DISEASES AND USE THEREOF
#3564ISOLATED MAMMALIAN MONOCYTE CELL GENES; RELATED REAGENTS
#3565Reliable stabilization of N-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns
#3566Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis
#3567Stromal Antigen 2 (STAG2) Compositions and Methods
#3568COMPOSITIONS AND METHODS FOR MONITORING BREAST CANCER TREATMENT
#3569Monoclonal antibodies and diagnostic uses thereof
#3570Promyelocytic leukemia protein as a redox sensor
#3571Antibody to peptide
#3572WISE/SOST NUCLEIC ACID SEQUENCES AND AMINO ACID SEQUENCES
#3573Muteins of tear lipocalin and methods for obtaining the same
#3574Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
#3575Peptide analogues
#3576METHOD FOR STABILIZATION OF PROTEINS USING NON-NATURAL AMINO ACIDS
#3577BLADDER CANCER BIOMARKER AND TEST METHOD USING THE SAME
#3578Tumor Antigens for the Prevention and/or Treatment of Cancer
#3579Modified ubiquitin proteins having a specific binding activity for the extradomain B of fibronectin
#3580DEATH ASSOCIATED PROTEIN 1 VARIANTS AND USE THEREOF FOR MODULATING AUTOPHAGY
#3581Polymer nanofiber scaffold for a heparin / fibrin based growth factor delivery system
#3582NUCLEIC ACID MOLECULES ENCODING BANK1 SPLICE VARIANTS
#3583Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof
#3584METHODS AND PRODUCTS RELATED TO METABOLIC INTERACTIONS IN DISEASE
#3585Biological Agents Active in Central Nervous System
#3586Methods of use of skin wound healing compositions
#3587EPITOPE TESTING USING SOLUBLE HLA
#3588Microorganisms having enhanced tolerance to inhibitors and stress
#3589ANTI-HLA ASSAY AND METHODS
#3590Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
#3591SMNdelta7 degron: novel compositions and methods of use
#3592Peptide vaccines for cancers expressing tumor-associated antigens
#3593Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
#3594Production of Therapeutic Proteins in Photosynthetic Organisms
#3595Activation of peptide prodrugs by hK2
#3596Methods and compositions for gene inactivation
#3597DNA vaccine against virus of yellow fever
#3598IMP-3 OLIGOPEPTIDES AND VACCINES INCLUDING THE SAME
#3599METHODS FOR TREATING DISEASES
#3600Method for inhibiting bone resorption